MK

Meena Kumari

Active Director Director DIN 05121975
DIN 05121975 First appointment Nov 2011 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2011
Shareholding value •••• Premium profile

About Meena Kumari

Data last updated:

Meena Kumari is a Director at Perianth Drugs Private Limited (since 2011). The company operates in Trading. Perianth Drugs Private Limited reported revenue of ₹39.7 Lakh (FY 2020).

DIN 05121975
Primary Designation Director
Industry Trading
First Appointment 30 Nov 2011
Oldest Company Age 14 yrs
Largest company Perianth Drugs Private Limited · ₹39.7 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Perianth Drugs Private Limited U24231HP2011PTC000007
Director30 Nov 20112011₹39.7 Lakh (FY 2020)Active

Board colleagues of Meena Kumari

NameDINCompanyDesignation
Vinod Kumar05121969Perianth Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Perianth Drugs Private Limited
Premium access

Shareholding and investment profile for Meena Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meena Kumari

Meena Kumari currently holds 1 directorship: Perianth Drugs Private Limited (Director, since 30 Nov 2011, revenue ₹39.7 Lakh (FY 2020)).

Meena Kumari was first appointed on 30 Nov 2011 as Director at Perianth Drugs Private Limited.

The current boards of Meena Kumari's companies include Vinod Kumar (Perianth Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available